Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Braude S., Nolop K. B., Fleming J. S., Krausz T., Taylor K. M., Royston D. Increased pulmonary transvascular protein flux after canine cardiopulmonary bypass. Association with lung neutrophil sequestration and tissue peroxidation. Am Rev Respir Dis. 1986 Nov;134(5):867–872. doi: 10.1164/arrd.1986.134.5.867. [DOI] [PubMed] [Google Scholar]
- Butler J., Rocker G. M., Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993 Feb;55(2):552–559. doi: 10.1016/0003-4975(93)91048-r. [DOI] [PubMed] [Google Scholar]
- Curzen N. P., Griffiths M. J., Evans T. W. Role of the endothelium in modulating the vascular response to sepsis. Clin Sci (Lond) 1994 Apr;86(4):359–374. doi: 10.1042/cs0860359. [DOI] [PubMed] [Google Scholar]
- Delgado R., Rojas A., Glaría L. A., Torres M., Duarte F., Shill R., Nafeh M., Santin E., González N., Palacios M. Ca(2+)-independent nitric oxide synthase activity in human lung after cardiopulmonary bypass. Thorax. 1995 Apr;50(4):403–404. doi: 10.1136/thx.50.4.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fowler A. A., Hamman R. F., Good J. T., Benson K. N., Baird M., Eberle D. J., Petty T. L., Hyers T. M. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med. 1983 May;98(5 Pt 1):593–597. doi: 10.7326/0003-4819-98-5-593. [DOI] [PubMed] [Google Scholar]
- Frostell C. G., Blomqvist H., Hedenstierna G., Lundberg J., Zapol W. M. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology. 1993 Mar;78(3):427–435. doi: 10.1097/00000542-199303000-00005. [DOI] [PubMed] [Google Scholar]
- KIRKLIN J. W., DONALD D. E., HARSHBARGER H. G., HETZEL P. S., PATRICK R. T., SWAN H. J., WOOD E. H. Studies in extracorporeal circulation. I. Applicability of Gibbon-type pump-oxygenator to human intracardiac surgery: 40 cases. Ann Surg. 1956 Jul;144(1):2–8. doi: 10.1097/00000658-195607000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KIRKLIN J. W. PULMONARY DYSFUNCTION AFTER OPEN-HEART SURGERY. Med Clin North Am. 1964 Jul;48:1063–1068. doi: 10.1016/s0025-7125(16)33436-8. [DOI] [PubMed] [Google Scholar]
- Kavanagh B. P., Mouchawar A., Goldsmith J., Pearl R. G. Effects of inhaled NO and inhibition of endogenous NO synthesis in oxidant-induced acute lung injury. J Appl Physiol (1985) 1994 Mar;76(3):1324–1329. doi: 10.1152/jappl.1994.76.3.1324. [DOI] [PubMed] [Google Scholar]
- Kirklin J. K., Westaby S., Blackstone E. H., Kirklin J. W., Chenoweth D. E., Pacifico A. D. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983 Dec;86(6):845–857. [PubMed] [Google Scholar]
- Kobzik L., Bredt D. S., Lowenstein C. J., Drazen J., Gaston B., Sugarbaker D., Stamler J. S. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol. 1993 Oct;9(4):371–377. doi: 10.1165/ajrcmb/9.4.371. [DOI] [PubMed] [Google Scholar]
- Liu S. F., Crawley D. E., Barnes P. J., Evans T. W. Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am Rev Respir Dis. 1991 Jan;143(1):32–37. doi: 10.1164/ajrccm/143.1.32. [DOI] [PubMed] [Google Scholar]
- Lorente J. A., Landín L., De Pablo R., Renes E., Liste D. L-arginine pathway in the sepsis syndrome. Crit Care Med. 1993 Sep;21(9):1287–1295. doi: 10.1097/00003246-199309000-00010. [DOI] [PubMed] [Google Scholar]
- Macnaughton P. D., Braude S., Hunter D. N., Denison D. M., Evans T. W. Changes in lung function and pulmonary capillary permeability after cardiopulmonary bypass. Crit Care Med. 1992 Sep;20(9):1289–1294. doi: 10.1097/00003246-199209000-00016. [DOI] [PubMed] [Google Scholar]
- Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993 Dec 30;329(27):2002–2012. doi: 10.1056/NEJM199312303292706. [DOI] [PubMed] [Google Scholar]
- Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
- Pepke-Zaba J., Higenbottam T. W., Dinh-Xuan A. T., Stone D., Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet. 1991 Nov 9;338(8776):1173–1174. doi: 10.1016/0140-6736(91)92033-x. [DOI] [PubMed] [Google Scholar]
- Petros A., Lamb G., Leone A., Moncada S., Bennett D., Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res. 1994 Jan;28(1):34–39. doi: 10.1093/cvr/28.1.34. [DOI] [PubMed] [Google Scholar]
- Rossaint R., Falke K. J., López F., Slama K., Pison U., Zapol W. M. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993 Feb 11;328(6):399–405. doi: 10.1056/NEJM199302113280605. [DOI] [PubMed] [Google Scholar]
- Szabó C., Mitchell J. A., Thiemermann C., Vane J. R. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol. 1993 Mar;108(3):786–792. doi: 10.1111/j.1476-5381.1993.tb12879.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
